 - Patients with type 2 diabetes mellitus who are not taking any treatment or are taking metformin with no change in the treatment, including dose, over the past 2 months. Subjects previously treated with a sulfonylurea in combination with metformin may be eligible if switched over to metformin only for a minimum of 4 weeks before dosing. 